Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK presents new efficacy and safety data of an anti GM-CSF antibody in patients with rheumatoid arthritis
- ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
- GSK updates policy for working with healthcare professionals
Tweets from GSK
-
GSK @GSK
#NEWS Rheumatoid arthritis still impacts 24.5 million people globally. Through our immunology research we are working to discover and develop new treatments to address this challenge. Read more in our press release gsk.to/2q3R2p6
about 1 hour ago -
GSK @GSK
A functioning immune system is crucial to our health. If it goes awry, it can lead to many diseases. That’s why #immunology is at the heart of our new approach to R&D: gsk.to/2NQIyLj #ACR18
about 19 hours ago
-
GSK @GSK
What’s the difference between pandemic and seasonal flu? @ThomasBreuer_MD, our Chief Vaccines Medic, shares some #flufacts #vaccinateforlife
about 23 hours ago
